EPITARGET
EPITARGET
EPITARGET

Partner 19 - Nanomerics Ltd.

Andreas Schatzlein Nanomerics Ltd

Prof. Andreas Schätzlein

Principal Investigator

Phone: +44 20 3397 2183

Fax: +44 20 3397 2184

undefinedE-Mail

 

undefinedPubMed

Nanomerics Ltd.

1394 High Road

London N20 9YZ

United Kingdom

undefinedWebsite

EPITARGET Team Nanomerics

Ijeoma Uchegbu

Prof. Ijeoma Uchegbu

CSO

Phone: +44 20 3397 2183

Fax: +44 20 3397 2184

undefinedE-Mail

Company presentation

NM is a biotech company commercialising nano-enabled delivery platforms which have the ability to delivery low molecular weight drugs, small peptides, and nucleic acids across various biological barriers. In particular, its MET technology has been shown to be able to overcome and bypass the BBB. NM has nano-enabled lead products due to commence clinical development. It has a specialist management team including founding scientists who are leading experts in the application of pharmaceutical nanotechnology (Prof AG Schatzlein, Prof IF Uchegbu) and experienced experts (e.g. A. Bye ex VP Discovery Medicine GSK) with extensive drug development experience, in particular with respect to the CNS. Nanomerics will provide input into WP3 Task 4 with a particular view to planning of the potential clinical and commercial development of therapeutic solutions emerging from the consortium.

EPITARGET Team

EPITARGET Consortium
 

EPITARGET Workpackages

EPITARGET Workpackages

Home
Menu
Search
Top

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

ARTTIC joins EPITARGET Read more

Social Media

Facebook EPITARGET
Home
Menu
Search
Top